Efficacy and Tolerability of Fimasartan, a New Angiotensin Receptor Blocker, Compared With Losartan (50/100 mg): A 12-Week, Phase III, Multicenter, Prospective, Randomized, Double-Blind, Parallel-Group, Dose Escalation Clinical Trial With an Optional 12-Week Extension Phase in Adult Korean Patients With Mild-to-Moderate Hypertension

Journal article published in 2012 by Sang Eun Lee, Yong-Jin Kim, Hae-Young Lee , Han-Mo Yang, Chang-Gyu Park, Jae-Joong Kim, Soon-Kil Kim, Moo-Yong Rhee, Byung-Hee Oh

This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Preprint: archiving allowed

Upload

Postprint: archiving restricted

Upload

Published version: archiving forbidden

Policy details

Data provided by